Welcome to LookChem.com Sign In|Join Free
  • or
N-(benzyloxycarbonyl)valienamine, also known as Z-Valienamine, is a chemical compound that serves as an important intermediate in the synthesis of pharmaceuticals and natural products. It is a derivative of valienamine, a naturally occurring compound found in certain plants, and is commonly used as a starting material for the preparation of new pharmaceutical agents. Z-Valienamine is known for its ability to selectively inhibit the activity of specific enzymes, making it a valuable tool in drug discovery and development. Furthermore, it has been studied for its potential anti-cancer and anti-viral properties, solidifying its importance in medicinal chemistry research.

83470-76-2

Post Buying Request

83470-76-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

83470-76-2 Usage

Uses

Used in Pharmaceutical Synthesis:
N-(benzyloxycarbonyl)valienamine is used as a key intermediate in the production of various drugs, contributing to the development of novel pharmaceutical agents.
Used in Biomolecule Modification:
Z-Valienamine is utilized in the modification of biomolecules for medicinal purposes, enhancing their therapeutic potential.
Used in Drug Discovery and Development:
As a selective enzyme inhibitor, N-(benzyloxycarbonyl)valienamine is employed in drug discovery and development processes to identify and optimize new therapeutic agents.
Used in Cancer Research:
In the field of cancer research, Z-Valienamine is studied for its potential anti-cancer properties, offering insights into the development of new cancer treatments.
Used in Antiviral Research:
N-(benzyloxycarbonyl)valienamine is also explored for its anti-viral properties, making it a significant compound in the search for new antiviral therapies.

Check Digit Verification of cas no

The CAS Registry Mumber 83470-76-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,3,4,7 and 0 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 83470-76:
(7*8)+(6*3)+(5*4)+(4*7)+(3*0)+(2*7)+(1*6)=142
142 % 10 = 2
So 83470-76-2 is a valid CAS Registry Number.

83470-76-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name N-(benzyloxycarbonyl)valienamine

1.2 Other means of identification

Product number -
Other names Valienamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:83470-76-2 SDS

83470-76-2Relevant academic research and scientific papers

Novel synthesis method of violienamine

-

, (2019/01/16)

The invention provides a novel synthesis method of violienamine. Specifically, the invention provides the novel synthesis method comprising the following steps: carrying out double-bond epoxidation reaction on an intermediate I to obtain an intermediate II; then carrying out rearrangement reaction on the intermediate I to obtain an intermediate III, i.e., violienamine with an amino protection group; removing the protection group from the intermediate II to obtain violienamine.

STEREOSELECTIVE CONVERSION OF VALIENAMINE AND VALIDAMINE INTO VALIOLAMINE

Horii, Satoshi,Fukase, Hiroshi,Kameda, Yukihiko

, p. 185 - 200 (2007/10/02)

Methods are described for the stereoselective conversion of valienamine (2) and validamine (3) into valiolamine (1a), a new pseudo-amino sugar isolated from the fermentation broth of Streptomyces hygroscopicus subsp. limoneus and which is a stronger α-D-glucosidase inhibitor than 2 and 3.Treatment of the acyclic carbamates (4) of 2 with halogenation reagents led to ring closure to afford the halo cyclic carbamates (6), which were reductively dehalogenated and then hydrolyzed to give 1a.Similar treatment of the exomethylene acyclic carbamate (12), derived from 3 via 8-11, resulted in the formation of halo cyclic carbamates (14a,b), which were converted into 1a.The synthesis of epivaliolamine (1b), the C-1 epimer of 1a, starting from 2 and 3, is also described.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 83470-76-2